Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. PRRUF
PRRUF logo

PRRUF News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PRRUF News

ASX Penny Stocks Highlight: DUG Technology Featured Among Three Key Selections

Dec 15 2025Yahoo Finance

Highlights of ASX Penny Stocks: Immutep and Two Other Notable Selections

Nov 16 2025Yahoo Finance

Immutep Ltd (PRRUF) Receives a Buy from Canaccord Genuity

Mar 07 2025Business Insider

Immutep Completes Enrolment for Promising INSIGHT-003 Cancer Trial

Jan 05 2025Business Insider

Immutep Reveals Promising Data for IMP761 Trial

Dec 16 2024Business Insider

Wall Street Analysts Are Bullish on Top Healthcare Picks

Dec 15 2024Business Insider

Immutep Initiates Phase III Trial for Lung Cancer

Dec 09 2024Business Insider

Immutep Limited Passes All AGM Resolutions

Nov 22 2024Business Insider

PRRUF Events

No data

No data

PRRUF Monitor News

No data

No data

PRRUF Earnings Analysis

No Data

No Data

People Also Watch